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relaxation and force development. Using synchrotron radiation small-angle x-ray scattering, this study investigated in the
in situ heart and in real-time whether changes in cross-bridge disposition and myosin interfilament spacing underlie the early
development of diabetic cardiomyopathy. Experiments were conducted using anesthetized Sprague-Dawley rats 3 weeks after
treatment with either vehicle (control) or streptozotocin (diabetic). Diffraction patterns were recorded during baseline and dobut-
amine infusions simultaneous with ventricular pressure-volumetry. From these diffraction patterns myosin mass transfer to actin
filaments was assessed as the change in intensity ratio (I1,0/I1,1). In diabetic hearts cross-bridge disposition was most notably
abnormal in the diastolic phase (p < 0.05) and to a lesser extent the systolic phase (p < 0.05). In diabetic rats only, there was
a transmural gradient of contractile depression. Elevated diabetic end-diastolic intensity ratios were correlated with the suppres-
sion of diastolic function (p< 0.05). Furthermore, the expected increase in myosin head transfer by dobutamine was significantly
blunted in diabetic animals (p < 0.05). Interfilament spacing did not differ between groups. We reveal that impaired cross-bridge
disposition and radial transfer may thus underlie the early decline in ventricular function observed in diabetic cardiomyopathy.INTRODUCTIONDiabetes is associated with impaired myocardial function in
the absence of underlying coronary vascular disease or
hypertension (1). This has been termed diabetic cardiomy-
opathy (DCM) and is characterized by impaired heart
muscle relaxation with a progressive increase in left ventric-
ular (LV) muscle stiffness and fibrosis eventually leading to
congestive heart failure (2). Several studies suggest that
diabetes and DCM are associated with cardiomyocyte
changes at the subcellular level resulting from abnormalities
in myocardial contractile and regulatory proteins (3–5). One
study using electron microscopy demonstrated disarray
within cardiac sarcomeric order and disorganization of the
mitochondrial matrix within advanced DCM hearts (6).
Accumulating evidence from animal models of DCM also
shows that the reduction in cardiac function is associated
with altered regulatory protein phosphorylation, a reduction
in myofibrillar ATPase activity, shifts in myosin enzyme
from the faster V1 to the slower V3 isoform, and a reduced
calcium uptake by the sarcoplasmic reticulum (7–10).
Furthermore, a slower time course of Ca2þ transients,
reduced decay time, slower contraction, and diminished
developed tension have been reported in the isolated DCM
heart (11). Combined with an increase in the activation of
oxidative stress cascades in DCM (12) leading to reactiveSubmitted October 15, 2012, and accepted for publication January 2, 2013.
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(13), and potential redox modifications of thin filament
proteins is likely to lead to functional defects in actin-
myosin cross-bridge formation (14). Joseph et al. (15)
have linked these functional changes in isolated LV papil-
lary muscle to altered cross-bridge dynamics by demon-
strating that DCM is associated with a reduction in the
number of active cross-bridges and subsequent alterations
in cross-bridge dynamics. Taken together, these studies
strongly suggest that functional depression of the cardiac
contractile apparatus contributes to DCM development.
However, previous work has primarily been performed
with cardiomyocytes, isolated cardiac muscle, or Langen-
dorff preparations and, although informative, uncertainty
remains as to the role changes in cardiac cross-bridge regu-
lation play in DCM in vivo.
Synchrotron radiation as a source for small-angle x-ray
diffraction has allowed the investigation of cardiac cross-
bridge dynamics in real time, in isolated muscle (16),
perfused hearts (17), and in situ in beating hearts (18–20).
Notably, the combined use of LV pressure-volumetry with
small-angle x-ray scattering (SAXS) has allowed us to
correlate regional actin-myosin cross-bridge dynamics
with changes in global cardiac function on a beat-to-beat
basis (19), which is essential to understanding DCM. The
aim of this investigation was to determine whether altered
regulation of cross-bridge disposition and myosin interfila-
ment spacing underlie the in vivo impairment in cardiac
function in a streptozotocin (STZ) rat model of DCM using
synchrotron SAXS.http://dx.doi.org/10.1016/j.bpj.2013.01.037
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Animals and experiments at the synchrotron
Experiments were conducted at Beamline 40XU at the Japan Synchrotron
Radiation Research Institute (SPring-8), Hyogo, Japan. Male Sprague
Dawley rats (Japan SLC, Kyoto, Japan, 7 weeks old) received either
a vehicle injection of sodium citrate (0.1M, pH 4) (control, n ¼ 7) or
STZ (65 mg/kg i.p.) (Sigma-Aldrich, Saint Louis, MI) to induce type 1
diabetes (n ¼ 9). Three weeks after vehicle or STZ injection all rats
underwent terminal experiments at Beamline 40XU.Animals and surgical preparation
Surgical preparations were similar to those described by us previously (19).
Under sodium pentobarbital anesthesia (50 mg/kg, i.p) (Nembutal, Dainip-
pon Sumitomo Pharma, Osaka, Japan), rats were intubated and artificially
ventilated. Supplemental anesthesia was maintained via further doses of
pentobarbital (30–40 mg/kg/h i.p.). Pancuronium bromide (Mioblock;
2 mg/kg i.m., Sankyo, Tokyo, Japan) was also administered to eliminate
spontaneous breathing when the ventilator was briefly switched off at
end-expiration during diffraction recordings, thereby limiting large fluctu-
ations in venous return. Rats were then thoractomized, providing access
to the heart, and a continuous flow of lactate Ringers solution was main-
tained to prevent drying of the exposed heart and lungs. The right jugular
vein was catheterized to facilitate drug delivery and fluid replacement,
thereby maintaining blood volume and a stable LV volume (lactate Ringers
solution, 2.0 ml/h, Otsuka Pharmaceuticals, Osaka, Japan after an initial
infusion of 50 units of heparin). The apex of the heart was then raised by
a micromanipulator and partly restrained by a plastic receptacle inserted
beneath the posterior apex, to limit vertical movements during recordings
and ensure maintenance of myocardial depth.Cardiac catheterization and volume calibration
Cardiac catheterization was performed to allow continuous LV pressure-
volume recordings simultaneous with all SAXS and arterial pressure
recordings. Calibration of the LV volume signal from relative volume units
to absolute volume was performed at the end of the experiment (19). Pres-
sure-volumetry was used to establish the timing of the cardiac cycle in all
treatment periods and to permit assessment of actin-myosin influence on
global LV function. Heart rate (HR) was determined from the interval
between end-diastolic (ED) events in the pressure-volume loops. Hemody-
namic data were recorded using CHART (v5.5.6, ADInstruments, NSW) at
a sampling rate of 1000/s.X-ray source, camera, and diffraction recordings
As described previously (19), a collimated quasimonochromatic beam with
0.08 nm wavelength (15 keV), dimensions 0.2  0.1 mm (horizontal 
vertical) and beam flux ~1012 photons/s (ring current 90–100 mA) was
focused on the surface myocardium at an oblique tangent (rat ~3m
from the detector). SAXS sequences (12 bit, 144  150 pixels) each
lasting <2.1 s were collected at a sampling interval of 15 ms with the aid
of an image intensifier (V5445P, Hamamatsu Photonics, Hamamatsu,
Japan) and a fast charge-coupled device camera (C4880-80-24A, Hama-
matsu Photonics). Patterns were then digitally recorded using HiPic32 soft-
ware (v5.1.0 Hamamatsu Photonics); see the Supporting Material.Experimental protocol
SAXS recordings were sequentially obtained during baseline intravenous
infusion of lactate Ringers (2.0 ml/h), 4.0 mg/kg/min and 8.0 mg/kg/min
dobutamine (Dobutrex, Eli Lilly Japan, Kobe Japan,) to assess myocardialBiophysical Journal 104(5) 1065–1072responses to increasing cardiac contractility and HR. At the termination
of experiments animals were euthanized with an overdose of potassium
chloride (KCl) solution (100 mM) and diffraction recordings were acquired
during complete muscle relaxation.Diffraction pattern analysis
SAXS patterns were analyzed using customized in-house software (HDA
version 3.0) over a minimum of five cardiac cycles (19). Lattice spacing
calibration was made using the 63.5-nm meridional reflection of collagen
present in a dried chicken tendon sample at the start of the experiments.
Using HDA custom software the average radial line profile around the
center of the spectrum was calculated using a three point background curve
fitting process with manual definition of peak spectra limits. Background
subtraction was then performed between user-defined inner and outer limits
on either side of the 1,0 and 1,1 reflections. The integrated intensity of the
1,0 and 1,1 reflection intensities was then determined from the areas under
the reflection peaks, defined as I1,0 and I1,1, respectively (21); see Fig. 1.
The 1,1 intensity, I1,1 was corrected with a
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tive to the 1,0 reflection (17,22). The integrated intensity was then further
multiplied by
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for the Lorentz factor; see theoretical consideration in
the Supporting Material. Because the number of fibers in the beam path
changes during contraction the equatorial intensity ratio (I1,0/I1,1) was
used to determine the shift of myosin mass (assumed to be predominately
cross-bridges) from the region of the thick filament to the thin filament.
The 1,0 reflection lattice spacing (d1,0) and 1,1 (d1,1) were obtained from
the center of gravity of the integrated 1,0 and 1,1 reflection at ED, end-
systolic (ES) and the maximal spacing.
The relative myosin mass transfer index, Dintensity ratio, was defined as
the change in intensity ratio between ED and the minimum intensity ratio,
which usually corresponded with ES. In addition, we calculated the radial
transfer of myosin heads to the thin filament as an absolute measure of
cross-bridge formation using the intensity ratios obtained in the minimum
and maximum cross-bridge attachment states. Peak and ED myosin mass
transfer to actin in control and diabetic hearts was therefore interpolated
using linear regression based on the intensity ratio in arrested hearts
following KCl (minimum cross-bridge attachments) and the minimum
attainable intensity ratio of 0.3 in the rigor state (maximum actin binding
site occupancy), based on previous findings (16,21,23,24). The number of
cross-bridges at diastole and during peak contraction was determined
from absolute myosin mass transfer, but no attempt was made to distinguish
weak and strongly binding states in the absence of meridional reflections.Statistical analysis
Values are expressed as mean 5 SE unless otherwise stated. Analyses to
assess the effect of drug infusions and myocardial layer were performed
using two-way and one-way ANOVA with Bonferroni post hoc testing to
account for repeated measures. An independent 2-tailed Student’s t-test
was performed to confirm differences between control and diabetic groups.
Linear regression was also used to test for significant correlations. The
Statistical Package Software System (SPSS v15, SPSS, Chicago, IL) was
used for all analysis with values of p < 0.05 deemed significant.RESULTS
Animal characteristics and basal LV function
Diabetic animals had a markedly elevated blood glucose
concentration (18.3 5 1.2 vs. 5.8 5 0.6 mmol,
p < 0.001) while maintaining a lower body weight
(2605 13 vs. 3555 36 g, p < 0.05) compared to controls.
FIGURE 1 Representative changes in epicardial equatorial reaction intensities recorded during 15-ms diffraction patterns in control and diabetic hearts
in vivo. Left panels (A, D, G, J) show x-ray diffraction patterns at ED (A, G) and ES (D, J) in a single control and diabetic heart. The intensity distributions
are shown in pseudocolor. The inner ring is the 1,0 reflection, whereas the outer equatorial reflection is 1,1. The middle panels (B, E, H, K) indicate average
radial intensity profiles around the center of the spectrum. Dashed lines indicate background intensity. In the rightmost panels (C, F, I, L) integrated reflection
intensities for 1,0 and 1,1 were fitted with Gaussian functions, where xc is reflection peak position and w is the peak-width (2 SD of peak).
Impaired Cross-Bridges in Early Diabetes 1067Mean arterial pressure before LV catheterization was not
significantly different between diabetic and control animals
(55.55 5.9 vs. 66.05 5.4 mm Hg, NS), although diabetes
did cause a depression in HR of ~80 bpm (p < 0.05).An impairment in diabetic systolic function was evident
as a lower ES pressure (p < 0.05) and a mild suppres-
sion of LV contractility evident as a diminished dP/dtmax
(p < 0.05) relative to the controls. Diastolic relaxationBiophysical Journal 104(5) 1065–1072
1068 Jenkins et al.was also impaired in diabetic animals, with a ~40% lower
dP/dtmin during baseline (p < 0.05) compared to controls.
There was also a nonsignificant trend toward a prolonged
diastolic active relaxation time with an increase in tau
(time constant of isovolumetric LV relaxation); see
summary in Table S1.Myosin mass transfer during basal contractions
Equatorial reflections from all animals showed clear 1,0 and
1,1 reflections due to the electron density around actin-
myosin filaments (see Fig. 1). Representative intensity ratio
sequences from a control and a diabetic rat illustrate the
well-defined cardiac cycles in intensity ratio; see Fig. S1.
Notably, the diabetic rat group was found to have a markedly
elevated ED intensity ratio in all layers compared to controls
(p < 0.05, Fig. 2 A). Minimum intensity ratio, indicative of
peak systolic cross-bridge attachments, was also unaffected
by myocardial depth in control rats. However, minimum
intensity ratio in diabetic animals was significantly greaterFIGURE 2 ED (A), systolic minimum (B), and systolic intensity ratio
change (C) in LV of control and diabetic rats during baseline (lactate
2 ml/h), low-dose dobutamine (4.0 mg/kg/min), and high-dose dobutamine
(8.0 mg/kg/min) sequential infusions in relation to myocardial layer.
Control, n ¼ 7 and diabetic n ¼ 9. yp < 0.05, zp < 0.01, yyp < 0.001 vs.
controls of same layer. *p < 0.05, #p < 0.01, ^p < 0.001 vs. baseline of
same layer.
Biophysical Journal 104(5) 1065–1072in all myocardial layers (p < 0.05, Fig. 2 B) compared to
controls and tended to increase with depth. Here, Dintensity
ratio (difference between ED and minimum ratio) in control
animals decreased slightly but not significantly as myocar-
dial depth increased (Fig. 2 C). Thus, nondiabetic rats
appeared to have a similar extent of cross-bridge formation
during baseline contractions throughout the examined
LV wall depth. This contrasted with diabetic rats where
Dintensity ratio increased with depth, and was markedly
higher in the subepicardial (p < 0.05) and subendocardial
(p < 0.05) layers (84% and 164%, respectively) compared
to control rats (Fig. 2 C). The larger Dintensity ratio in dia-
betic rats suggests that myosin mass transfer is enhanced
compared to control rats, but absolute myosin transfer did
not agree with this finding.
SAXS patterns recorded following diastolic arrest with
KCl infusion (see Fig. S2) were used to determine myosin
mass transfer with no cross-bridge attachments and subse-
quently absolute myosin mass transfer during contractions.
The quiescent intensity ratio found in diabetic rats (4.0–
4.5) was higher than control rats and all previous reports
at ~3.0 (16,23). A trend toward a ~15–20% lower basal
peak systolic myosin mass transfer was found in all layers
of diabetic hearts compared to controls (Fig. 3 A). Of impor-
tance, the number of myosin heads in the proximity of actin
at ED in control rats was ~20–40% of the total potential
myosin mass transfer, thus a significant amount of myosin
projections remain close to actin between contractions
without developing force. A trend toward a lower basalFIGURE 3 Systolic (A) and ED (B) myosin mass transfer in control and
diabetic rat hearts during baseline (lactate 2 ml/h), low-dose dobutamine
(4.0 mg/kg/min), and high-dose dobutamine (8.0 mg/kg/min) infusion.
Control, n ¼ 7 and diabetic n ¼ 9. yp < 0.05, zp < 0.01 vs. controls of
same layer.
Impaired Cross-Bridges in Early Diabetes 1069diabetic ED myosin mass transfer relative to controls was
found in all myocardial layers, and significantly lower in
the subepicardium (p < 0.05, Fig. 3 B).
Among the rats in the diabetic group basal ED intensity
ratio was positively correlated with the minimum rate of
LV pressure decrease during diastole (dP/dtmin) and there-
fore global LV relaxation (Fig. 4). This relation in diabetic
animals was significantly different in slope from zero in
the subepicardial layer (p < 0.05); similar trends were
also evident in other layers; see Fig. S3. As the ED intensity
ratio increased in diabetic rat hearts diastolic function wors-
ened. No such correlation was found in control animals.Global LV response to dobutamine
Despite the lower absolute HR in diabetic animals, the
change in HR and MAP from baseline during dobutamine
infusion was not significantly different between groups.
Although the ejection fraction was slightly enhanced during
low-dose dobutamine infusion in diabetic animals (p <
0.05), contractility was depressed during high-dose dobut-
amine as the LV dP/dtmax increase from baseline was greatly
reduced (~30% of control). Notably, ES LV pressure re-
mained ~70 mmHg lower in diabetic rats compared to
controls during both low-dose dobutamine (p < 0.01) and
high-dose dobutamine (p < 0.05); as detailed in Table S1.
LV relaxation (dP/dtmin) in diabetic rats was impaired and
remained ~50% lower during both low-dose (p < 0.01)
and high-dose dobutamine (p < 0.05) infusions when
compared to control animals.Effect of dobutamine stimulation on local myosin
mass transfer and cross-bridge formation
In general, differences in ED, minimum intensity ratio, and
Dintensity ratio between control and diabetic animals
observed at baseline were unchanged following low- or
high-dose dobutamine infusion. In response to low-doseFIGURE 4 Diastolic relaxation (dP/dtmin) in relation to ED intensity ratio
in individual control and diabetic rats during baseline (lactate 2 ml/h) condi-
tions. In diabetic animals there was a significant difference in slope from
zero in the subepicardium. Control, n ¼ 7 and diabetic n ¼ 9.dobutamine, systolic mass transfer increased comparably
in both control (~9%) and diabetic groups (~8%) relative to
baseline treatment across all myocardial layers (Fig. 3 A).
However, systolic cross-bridge formation was ~18%
lower in diabetic animals compared to controls, notably in
the subendocardium (p < 0.05). The change in ED myosin
mass transfer during low-dose dobutamine infusion from
baseline was similar in both groups but remained ~30
to ~40% lower in diabetic hearts compared to controls
across all myocardial layers, especially in the subepicar-
dium (p < 0.05, Fig. 3 B).
Systolic and ED mass transfer were further increased by
high-dose dobutamine infusion in controls in contrast to
the response in diabetic rodents (Fig. 3). Nevertheless, the
extent of systolic myosin mass transfer was consistent
across the myocardial wall within both groups, but was
significantly lower in diabetics compared to controls
(p < 0.05). Systolic myosin mass transfer and cross-bridge
attachments decreased in some diabetic rat hearts relative to
the basal state during high-dose dobutamine; see Fig. S4.Effect of diabetes and dobutamine on
interfilament spacing
Under basal conditions there was no significant transmural
difference in interfilament (d1,0) spacing in either group.
We did however observe a smaller ED d1,0 spacing
(~1.0 nm smaller) in diabetic animals compared to control
rats in the subepicardial (p < 0.05) and subendocardial
(p < 0.05) layers (Fig. 5). Neither low-dose nor high-dose
dobutamine infusion had a significant effect on d1,0 spacing,
see Fig. S5. Taken together, the diminished changes in
myosin transfer and LV pressure development changes
observed in diabetic rat hearts paralleled the reduced change
in myofilament lattice expansion.DISCUSSION
To our knowledge, this is the first in situ study to investigate
cardiac cross-bridge regulation and interfilament spacing in
the early diabetic rodent heart using a synchrotron radiationFIGURE 5 ED d1,0 spacing in LV of control and diabetic rats during
baseline (lactate 2 ml/h), low-dose dobutamine (4.0 mg/kg/min), and
high-dose dobutamine (8.0 mg/kg/min) sequential infusions. Values ex-
pressed as mean5 SE. yp < 0.05 vs. controls for the same layer.
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cardiac dysfunction is associated with an increased intensity
ratio, a measure of the relative electron density shift
between myosin thick filaments and actin thin filaments,
and a corresponding reduction in cardiac cross-bridge
formation that was in part due to displacement of myosin
heads from actin filaments particularly during diastole.
Furthermore, diabetic subendocardial rather than epicardial
layers appear to be more susceptible to early contractile
impairment as greater intensity ratios were observed with
increased depth in the myocardium. This early impairment
was further confirmed as cross-bridge formation remained
markedly depressed following cardiac-stress testing with
the b-adrenergic agonist dobutamine. These early changes
occur in the absence of marked alterations in interfilament
spacing and therefore, we also assume to occur in the
absence of significant sarcomere length changes because
d1,0 is directly related to sarcomere length in intact muscle
(25). Hence, these findings provide evidence that early
type 1 diabetic cardiomyopathy also results from impair-
ment in myosin head extension and/or flexibility.
At 3 weeks post STZ induction all diabetic rats had
impaired diastolic relaxation and systolic contraction as
a result of persistent hyperglycemia. This is consistent
with previously reported changes in cardiac function in
early diabetes (26). Of importance, in early stage diabetes
this cardiac dysfunction likely occurs in the absence of
cardiac structural changes such as collagen accumulation
(27), and suggests that other mechanisms such as subcellular
alterations in the contractile apparatus must play a role.Baseline cross-bridge disposition in diabetes
We confirmed that ED and ES intensity ratios in nondiabetic
hearts were within the previously described range using
synchrotron SAXS of around 0.8–2.5 (17,19). In contrast,
we found that diabetic rats had a marked increase in the
minimum, ED, and ES intensity ratios between 1.5 and
4.5, with higher ratios consistently found in the subendocar-
dium. This is notable as there are no reports of diastolic or
resting intensity ratios >3.5 for perfused hearts or ex vivo
cardiac muscle (21,24,25). Because the 1,1 reflection is
observed continuously over the cardiac cycle in our SAXS
recordings of the diabetic hearts, the observation of reduced
mass associated with actin is unlikely to be an artifact.
Between animal comparisons revealed that the elevated
baseline intensity ratio observed in diabetic hearts at ED
was directly negatively correlated with HR (see Fig. S6),
and the rate of LV pressure change during contraction posi-
tively correlated with dP/dtmin, the rate of relaxation. The
negative correlation between HR and intensity ratio is ex-
pected as HR is intimately related to calcium homeostasis,
contractile force, and thus cardiac function (28). However,
bradycardia only explains the abnormally elevated ED
intensity ratio in diabetic rodents in part because the EDBiophysical Journal 104(5) 1065–1072ratio exceeded the intensity ratio of KCl relaxed nondiabetic
muscle, and in the same diabetic hearts the ratio increased
with myocardial depth from the epicardium. These findings
suggest that beyond a prolonged interbeat interval an under-
lying impairment in actin-myosin filament regulation is the
primary cause of cardiac dysfunction in early DCM.Mass transfer during basal contractions in
diabetic hearts
We found that absolute basal myosin mass transfer at ED
was appreciably reduced in early diabetes, in contrast to
inferences drawn from the Dintensity ratio as the quiescent
intensity ratio was elevated. In one of the first studies to
apply SAXS to cross-circulated heart preparations, ~50%
of myosin projections remained in the presence of the thin
actin filament during diastole in papillary muscle under
near physiological cyclic contractions (29); even though
no force is developed by these myosin heads between
systolic contractions. This is similar to our control values
but is markedly greater than that which we observed in early
diabetes where only ~5% of myosin projections remained in
the presence of the thin filament. Displacement of myosin
mass to the thin filaments during the early phase of contrac-
tion has been shown to alter the rate of force development
(22). Indeed, Matsubara and associates have shown that
the number of myosin heads near actin during diastole is
directly related to the inotropic state in cardiac muscle
(30). In diabetes myosin isoform changes are known to
play a large role in the reduced cross-bridge kinetics
(3,31), which is consistent with the reduced ESP in diabetic
hearts. However, in the early stage of diabetes it is likely that
the greatly diminished proportion of myosin heads in the
proximity of actin, which also contributes to the depression
in the rate of force development and cardiac dysfunction.
This agrees with the previous finding in STZ-induced dia-
betic rat heart muscle where the impairment in contractile
function was due to a reduction in total active cross-bridge
number and altered kinetics rather than a change in the force
of a single cross-bridge (15). As such, the early decline in
diabetic cardiac function likely results from a deficit in
strongly bound cross-bridge attachments.Nonuniformity of transmural cross-bridge
regulation in diabetes
The subendocardium has long been thought to be the most
susceptible myocardial region to ischemic injury (32),
although more recently susceptibility has been shown to
be more closely related to the extent of collateral vessels
(33). Nevertheless, our findings in diabetic rodents show
that impairment in cross-bridge dynamics initially occurs
to a greater extent in the subendocardial region. Preliminary
evaluation of cross-bridge disposition in progressively
deeper myocardial layers of the diabetic heart uncovered
Impaired Cross-Bridges in Early Diabetes 1071a strong trend toward more exaggerated dysfunction due to
reduced myosin mass transfer, but 1,1 reflection intensity is
no longer consistently present for detailed analysis. Greater
subendocardial pathology appears to be consistent with
reports in human type 2 diabetes patients who have no
history of clinical heart disease but present initially with
subendocardial LV dysfunction at rest and during peak
stress (34). One difficulty associated with the in situ method
is that diffraction recordings from the deeper subendocardial
and subepicardial layers contain information about the
epicardial regions, making it challenging to delineate
specific contributions due to the possibility of differential
activation. Nevertheless, these findings show that subendo-
cardial rather than epicardial impairment in cross-bridge
regulation occurs preferentially in early diabetes.No clear role for interfilament spacing in early
diabetic dysfunction
Interfilament spacing at ED is directly correlated with the
number of cross-bridges that can form attachments in the
next cardiac cycle (19). Potentially, the increased diabetic
intensity ratio and reduction in cross-bridge formation could
result from a change in lattice spacing as demonstrated in
relaxed skinned cardiac muscle (35) and/or reduced myofil-
ament overlap at short sarcomere length (36). However, in
diabetics a slightly smaller ED d1,0 was balanced by normal
d1,0 spacing during isovolumetric contraction compared to
controls.Diminished cross-bridge recruitment during
b-adrenergic stimulation
A major finding of this study is that dobutamine stimulation
uncovered a blunted b-adrenoceptor response in diabetic
systolic cross-bridge formation and diastolic mass transfer
compared to both our control rats and another study in
nondiabetic mice (20). The data presented here clearly
show that diastolic myosin mass transfer is an important
determinant of cross-bridge recruitment in positive inotropy.
In control rat hearts diastolic myosin mass transfer was 60–
80% at the higher dobutamine dose. This pronounced reduc-
tion in the intensity ratio is assumed to be due to radial mass
transfer of myosin projections and not azimuthal movement
as first demonstrated by Haselgrove and Huxley (37).There-
fore, it is suggested that an increase in diastolic mass trans-
fer results in an increase in weak cross-bridge formation as
these projections do not develop force. In the early stage of
diabetic heart, we found little evidence of a significant
increase in the proximity of myosin heads to actin filaments
or an appreciable increase in global cardiac contractility
during dobutamine stimulation. A trend for a small increase
in diastolic myosin mass transfer in the deeper myocardial
layers did not result in a concomitant increase in systolic
mass transfer. b-adrenergic stimulation did not affect dia-betic lattice spacing (20) and therefore we assume did not
alter the sarcomere length operating range. It should be
noted however that neither low-dose nor high-dose dobut-
amine was sufficient to increase HR from baseline in either
group of open-chest rats. This contrasts with closed-chest
mice where b-adrenoceptor activation evoked a modest
increase in HR (20). The lack of a positive chronotropic
response to dobutamine in our study appears to be due to
the open-chest preparation. Nevertheless, the increase in
diastolic myosin mass associated with actin during the
increase in positive inotropy is not directly due to a shorter
diastolic interval between contractions and cannot be ex-
plained by a reduced interval for relaxation of fibers to allow
myosin heads to return to the myosin backbone.
Possible mechanisms underlying the reduction in the
number of myosin heads in close proximity to actin fila-
ments are unclear, however prior work suggests that myosin
binding protein-C (MyBP-C) or regulatory light chain
(RLC) might be important. MyBP-C plays a role in altering
myosin head order, myosin head extension (38), and plays
a role in sustaining cardiac force and stiffness to maintain
cardiac function (39). Phosphorylation of MyBP-C leads
to greater cross-bridge extension from the thick filament
backbone and an increase in myosin filament order and
orientation (38). Notably, in Drosophila it has been shown
that RLC is a more important determinant of the orientation
and proximity of myosin heads to actin and twitch force
development than interfilament spacing (40). Therefore,
the roles MyBP-C and RLC play in reduced myosin head
interaction and cross-bridge formation in early stage dia-
betes requires further investigation. Although alterations
in troponin-I and myosin heavy chain isoforms have been
demonstrated to be a major determinant of reduced cross-
bridge kinetics in diabetic cardiac muscle (3,31) neither of
these changes influence myosin head extension.
In summary, we have shown with real-time synchrotron
x-ray diffraction, that early in diabetes, impairment in the
regulation of myosin head extension occurs in the heart,
contributing to the reduction in its ability to increase cardiac
force. Our data show that in diabetes, myosin heads are dis-
placed from actin filaments in beating heart muscle fibers. A
lack of diastolic myosin mass transfer to actin was directly
related to impaired LV function and contributed to the
reduction in systolic strong cross-bridge formation during
increased positive inotropic stimulation and a progressively
greater impairment in deeper myocardial layers.SUPPORTING MATERIAL
Materials, methods, six figures, and reference (41) are available at http://
www.biophysj.org/biophysj/supplemental/S0006-3495(13)00142-2.
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